Related Experiment Video
Updated: May 5, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Pulmonary Necrotizing Granulomas in a patient with familial mediterranean fever
Hisako Kushima1, Hiroshi Ishii, Koji Ishii
1a Department of Respiratory Medicine , Oita University Hospital , Oita , Japan.
Abstract:
We herein report a case of familial Mediterranean fever (FMF) presenting with granulomatous lung lesions with neuronal apoptosis inhibitory protein (NAIP), MHC class II transcription activator (CIITA), incompatibility locus protein from Podospora anserina (HET-E), and telomerase-associated protein (TP1) (NACHT) leucine-rich-repeat 1-positive inflammatory cell infiltrates. FMF is an autoinflammatory disorder characterized by recurrent and self-limited attacks of pyrexia, arthritis and erysipelas-like skin lesions. Lung disorders associated with FMF are extremely rare. This is the first report of an immunologically-confirmed case of pulmonary manifestations of this disease.
Insights
Familial Mediterranean Fever (FMF) can rarely cause lung inflammation. This case highlights granulomatous lung lesions with specific inflammatory cell infiltrates, offering new insights into FMF pulmonary manifestations.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Familial Mediterranean Fever (FMF) is a rare autoinflammatory disorder.
- FMF typically presents with recurrent fever, arthritis, and skin lesions.
- Pulmonary involvement in FMF is exceptionally uncommon.
Observation:
- A case of FMF presented with unusual granulomatous lung lesions.
- These lesions showed specific inflammatory cell infiltrates.
- The infiltrates were positive for NACHT-LRR1, including NAIP, CIITA, HET-E, and TP1 proteins.
Findings:
- This study details the first immunologically confirmed case of pulmonary FMF.
- The findings reveal a unique presentation of granulomatous lung disease in FMF.
- Specific protein markers were identified in the inflammatory infiltrates.
Implications:
- This report expands the known clinical spectrum of Familial Mediterranean Fever.
- It underscores the importance of considering FMF in patients with unexplained pulmonary granulomatous disease.
- Further research into the pathogenesis of FMF-associated lung disease is warranted.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Myocarditis II: Clinical Features and Diagnostic Tests
Pneumonia II: Pathophysiology
Atypical Pneumonia
Myocarditis I: Introduction

